Repetitive TMS to relieve neuropathic pain after spinal cord injury
Official title: The Effect of Transcranial Magnetic Stimulation Applied to the Primary Motor Cortex and Anterior Cingulate Cortex on Refractory Neuropathic Pain in Spinal Cord Injury
Run by Ankara Etlik City Hospital · NCT07293780 · Data updated 2026-11-12
This trial will test whether rTMS aimed at the anterior cingulate cortex reduces chronic neuropathic pain in adults with spinal cord injury compared with motor cortex stimulation or a sham treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 39 (estimated) |
| Sponsor | Ankara Etlik City Hospital Government |
| Locations | 2 sites (Ankara, Yenimahalle and 1 other locations) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | May 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07293780 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 who are at least 12 months post–spinal cord injury, have central neuropathic pain below the lesion for ≥6 months with VAS > 4 despite medications and therapy, and meet safety criteria for TMS.
✕Probably not a fit
Patients with a history of epilepsy, metallic or electronic cranial implants, spinal cord stimulators, pacemakers, significant psychiatric illness, pregnancy, or pain attributable to other causes (e.g., diabetes, rheumatologic disease) are unlikely to benefit or are ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic central neuropathic pain after spinal cord injury will receive repetitive transcranial magnetic stimulation (rTMS) targeted to the anterior cingulate cortex, compared with motor cortex stimulation and sham TMS. The intervention arms include active and sham TMS; treatments are delivered in person at participating hospitals. Eligible participants are 18–65 years old, at least 12 months post-injury, with pain below the lesion for at least 6 months and VAS > 4 despite standard pharmacologic and rehabilitative care. Exclusions include epilepsy, metallic or electronic cranial implants, spinal cord stimulator, pacemaker, significant psychiatric illness, and pregnancy; pain due to other causes is also excluded.
Why it matters
Potential benefit: If successful, the intervention could reduce chronic neuropathic pain and improve daily function and quality of life for people with spinal cord injury.
How similar studies have gone: Previous studies of motor cortex rTMS have shown modest benefits for neuropathic pain, while anterior cingulate targeting is a more novel approach with limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients for whom at least 12 months have passed since the date of the spinal cord injury 2. Patients who meet the International Spinal Cord Injury Pain (ISCIP) Classification criteria for central neuropathic pain below the level of the lesion and who have had pain for at least 6 months 3. Patients aged 18-65 4. Pain not attributable to other causes such as rheumatological diseases or diabetes 5. Patients with VAS \> 4 despite maximum dose of pharmacological agents (anticonvulsants, antidepressants, opioids), exercise and physical therapy agents, taking into account renal function tests and other comorbidities Exclusion Criteria: 1. History of epilepsy 2. Metallic implant in the scalp 3. Cochlear implant 4. Spinal cord stimulator 5. Pacemaker 6. Presence of psychiatric illness 7. Pregnancy
Where it's running
-
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye) Recruiting -
Gaziler Physical Therapy and Rehabilitation Training and Research Hospital
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Ayşe Naz Kalem, Specialist — Ankara Etlik City Hospital
- Study coordinator: Ayşe Naz Kalem Özgen, specialist
- Email: kalemnaz@gmail.com
- Phone: +90 312 797 00 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Calcitonin treatment for neuropathic pain after spinal cord injury
This study is testing if calcitonin can help reduce the pain that people experience after a spinal cord injury compared to a placebo.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.